Patents by Inventor Girisha Meenkere

Girisha Meenkere has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bosutinib forms and preparation methods thereof
    Patent number: 9776970
    Abstract: The present subject matter relates to solvates and the amorphous form of bosutinib; the solvates namely being a propylene glycol solvate and an acetonitrile solvate. Also provided are processes for preparing the propylene glycol solvate, the amorphous form and the crystalline acetonitrile solvate of bosutinib; as well as compositions comprising said forms. Bosutinib is a 3-quinolinecarbonitrile kinase inhibitor and is indicated for the treatment of adult patients with chronic, accelerated, or blast phase Ph+ chronic myelogenous leukemia (CMS) with resistance or intolerance to prior therapy.
    Type: Grant
    Filed: February 20, 2015
    Date of Patent: October 3, 2017
    Assignee: Apotex Inc.
    Inventors: Padiyath Mohammed Akbarali, Venkata Ramana Kintali, Heggadde Nanjunda Bhatta Shreenivasa Murthy, Girisha Meenkere, Somanath Bhupal Venkata, Raja Ramesh Manda, Vishal Amrutlal Sodha, Abbulu Kante
  • Bosutinib Forms and Preparation Methods Thereof
    Publication number: 20170057923
    Abstract: The present subject matter relates to solvates and the amorphous form of bosutinib; the solvates namely being a propylene glycol solvate and an acetonitrile solvate. Also provided are processes for preparing the propylene glycol solvate, the amorphous form and the crystalline acetonitrile solvate of bosutinib; as well as compositions comprising said forms. Bosutinib is a 3-quinolinecarbonitrile kinase inhibitor and is indicated for the treatment of adult patients with chronic, accelerated, or blast phase Ph+ chronic myelogenous leukemia (CMS) with resistance or intolerance to prior therapy.
    Type: Application
    Filed: February 20, 2015
    Publication date: March 2, 2017
    Applicant: Apotex Inc.
    Inventors: Padiyath Mohammed Akbarali, Venkata Ramana Kintali, Heggadde Nanjunda Bhatta Shreenivasa Murthy, Girisha Meenkere, Somanath Bhupal Venkata, Raja Ramesh Manda, Vishal Amrutlal Sodha, Abbulu Kante